
Bioinformatics is an interdisciplinary field that develops methods and software tools for understanding biological data. As an interdisciplinary field of science, bioinformatics combines biology, computer science, mathematics and statistics to analyze and interpret biological data. Bioinformatics has been used for in silico analyses of biological queries using mathematical and statistical techniques.
Highlights
The global Bioinformatics market was valued at US$ 7626.5 million in 2022 and is anticipated to reach US$ 12240 million by 2029, witnessing a CAGR of 8.2% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Bioinformatics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Bioinformatics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Bioinformatics in Genomics is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Bioinformatics include Thermo Fisher Scientific (US), Agilent Technologies (US), Illumina Inc (US), QIAGEN (Netherlands), Partek (US), BGI (China), Waters Corporation (US), Sophia Genetics (Switzerland) and Wuxi NextCODE (China), etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Bioinformatics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bioinformatics.
The Bioinformatics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Bioinformatics market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bioinformatics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Thermo Fisher Scientific (US)
Agilent Technologies (US)
Illumina Inc (US)
QIAGEN (Netherlands)
Partek (US)
BGI (China)
Waters Corporation (US)
Sophia Genetics (Switzerland)
Wuxi NextCODE (China)
Eurofins Scientific (Luxembourg)
DNASTAR (US)
Segment by Type
Knowledge Management Tools
Data Analysis Platforms
Segment by Application
Genomics
Chemoinformatics and Drug Design
Proteomics
Transcriptomics
Metabolomics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bioinformatics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bioinformatics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Knowledge Management Tools
1.2.3 Data Analysis Platforms
1.3 Market by Application
1.3.1 Global Bioinformatics Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Genomics
1.3.3 Chemoinformatics and Drug Design
1.3.4 Proteomics
1.3.5 Transcriptomics
1.3.6 Metabolomics
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Bioinformatics Market Perspective (2018-2029)
2.2 Bioinformatics Growth Trends by Region
2.2.1 Global Bioinformatics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Bioinformatics Historic Market Size by Region (2018-2023)
2.2.3 Bioinformatics Forecasted Market Size by Region (2024-2029)
2.3 Bioinformatics Market Dynamics
2.3.1 Bioinformatics Industry Trends
2.3.2 Bioinformatics Market Drivers
2.3.3 Bioinformatics Market Challenges
2.3.4 Bioinformatics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bioinformatics Players by Revenue
3.1.1 Global Top Bioinformatics Players by Revenue (2018-2023)
3.1.2 Global Bioinformatics Revenue Market Share by Players (2018-2023)
3.2 Global Bioinformatics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Bioinformatics Revenue
3.4 Global Bioinformatics Market Concentration Ratio
3.4.1 Global Bioinformatics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bioinformatics Revenue in 2022
3.5 Bioinformatics Key Players Head office and Area Served
3.6 Key Players Bioinformatics Product Solution and Service
3.7 Date of Enter into Bioinformatics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Bioinformatics Breakdown Data by Type
4.1 Global Bioinformatics Historic Market Size by Type (2018-2023)
4.2 Global Bioinformatics Forecasted Market Size by Type (2024-2029)
5 Bioinformatics Breakdown Data by Application
5.1 Global Bioinformatics Historic Market Size by Application (2018-2023)
5.2 Global Bioinformatics Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Bioinformatics Market Size (2018-2029)
6.2 North America Bioinformatics Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Bioinformatics Market Size by Country (2018-2023)
6.4 North America Bioinformatics Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Bioinformatics Market Size (2018-2029)
7.2 Europe Bioinformatics Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Bioinformatics Market Size by Country (2018-2023)
7.4 Europe Bioinformatics Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Bioinformatics Market Size (2018-2029)
8.2 Asia-Pacific Bioinformatics Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Bioinformatics Market Size by Region (2018-2023)
8.4 Asia-Pacific Bioinformatics Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Bioinformatics Market Size (2018-2029)
9.2 Latin America Bioinformatics Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Bioinformatics Market Size by Country (2018-2023)
9.4 Latin America Bioinformatics Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bioinformatics Market Size (2018-2029)
10.2 Middle East & Africa Bioinformatics Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Bioinformatics Market Size by Country (2018-2023)
10.4 Middle East & Africa Bioinformatics Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific (US)
11.1.1 Thermo Fisher Scientific (US) Company Detail
11.1.2 Thermo Fisher Scientific (US) Business Overview
11.1.3 Thermo Fisher Scientific (US) Bioinformatics Introduction
11.1.4 Thermo Fisher Scientific (US) Revenue in Bioinformatics Business (2018-2023)
11.1.5 Thermo Fisher Scientific (US) Recent Development
11.2 Agilent Technologies (US)
11.2.1 Agilent Technologies (US) Company Detail
11.2.2 Agilent Technologies (US) Business Overview
11.2.3 Agilent Technologies (US) Bioinformatics Introduction
11.2.4 Agilent Technologies (US) Revenue in Bioinformatics Business (2018-2023)
11.2.5 Agilent Technologies (US) Recent Development
11.3 Illumina Inc (US)
11.3.1 Illumina Inc (US) Company Detail
11.3.2 Illumina Inc (US) Business Overview
11.3.3 Illumina Inc (US) Bioinformatics Introduction
11.3.4 Illumina Inc (US) Revenue in Bioinformatics Business (2018-2023)
11.3.5 Illumina Inc (US) Recent Development
11.4 QIAGEN (Netherlands)
11.4.1 QIAGEN (Netherlands) Company Detail
11.4.2 QIAGEN (Netherlands) Business Overview
11.4.3 QIAGEN (Netherlands) Bioinformatics Introduction
11.4.4 QIAGEN (Netherlands) Revenue in Bioinformatics Business (2018-2023)
11.4.5 QIAGEN (Netherlands) Recent Development
11.5 Partek (US)
11.5.1 Partek (US) Company Detail
11.5.2 Partek (US) Business Overview
11.5.3 Partek (US) Bioinformatics Introduction
11.5.4 Partek (US) Revenue in Bioinformatics Business (2018-2023)
11.5.5 Partek (US) Recent Development
11.6 BGI (China)
11.6.1 BGI (China) Company Detail
11.6.2 BGI (China) Business Overview
11.6.3 BGI (China) Bioinformatics Introduction
11.6.4 BGI (China) Revenue in Bioinformatics Business (2018-2023)
11.6.5 BGI (China) Recent Development
11.7 Waters Corporation (US)
11.7.1 Waters Corporation (US) Company Detail
11.7.2 Waters Corporation (US) Business Overview
11.7.3 Waters Corporation (US) Bioinformatics Introduction
11.7.4 Waters Corporation (US) Revenue in Bioinformatics Business (2018-2023)
11.7.5 Waters Corporation (US) Recent Development
11.8 Sophia Genetics (Switzerland)
11.8.1 Sophia Genetics (Switzerland) Company Detail
11.8.2 Sophia Genetics (Switzerland) Business Overview
11.8.3 Sophia Genetics (Switzerland) Bioinformatics Introduction
11.8.4 Sophia Genetics (Switzerland) Revenue in Bioinformatics Business (2018-2023)
11.8.5 Sophia Genetics (Switzerland) Recent Development
11.9 Wuxi NextCODE (China)
11.9.1 Wuxi NextCODE (China) Company Detail
11.9.2 Wuxi NextCODE (China) Business Overview
11.9.3 Wuxi NextCODE (China) Bioinformatics Introduction
11.9.4 Wuxi NextCODE (China) Revenue in Bioinformatics Business (2018-2023)
11.9.5 Wuxi NextCODE (China) Recent Development
11.10 Eurofins Scientific (Luxembourg)
11.10.1 Eurofins Scientific (Luxembourg) Company Detail
11.10.2 Eurofins Scientific (Luxembourg) Business Overview
11.10.3 Eurofins Scientific (Luxembourg) Bioinformatics Introduction
11.10.4 Eurofins Scientific (Luxembourg) Revenue in Bioinformatics Business (2018-2023)
11.10.5 Eurofins Scientific (Luxembourg) Recent Development
11.11 DNASTAR (US)
11.11.1 DNASTAR (US) Company Detail
11.11.2 DNASTAR (US) Business Overview
11.11.3 DNASTAR (US) Bioinformatics Introduction
11.11.4 DNASTAR (US) Revenue in Bioinformatics Business (2018-2023)
11.11.5 DNASTAR (US) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Thermo Fisher Scientific (US)
Agilent Technologies (US)
Illumina Inc (US)
QIAGEN (Netherlands)
Partek (US)
BGI (China)
Waters Corporation (US)
Sophia Genetics (Switzerland)
Wuxi NextCODE (China)
Eurofins Scientific (Luxembourg)
DNASTAR (US)
Ìý
Ìý
*If Applicable.
